Literature DB >> 7621072

CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18.

S Lecoanet-Henchoz1, J F Gauchat, J P Aubry, P Graber, P Life, N Paul-Eugene, B Ferrua, A L Corbi, B Dugas, C Plater-Zyberk.   

Abstract

CD23 is expressed on a variety of haemopoietic cells and displays pleiotropic activities in vitro. We report that in addition to CD21 and IgE, CD23 interacts specifically with the CD11b and CD11c, the alpha chains of the beta 2 integrin adhesion molecule complexes CD11b-CD18 and CD11c-CD18, on monocytes. Full-length recombinant CD23 incorporated into fluorescent liposomes was shown to bind to COS cells transfected with cDNA encoding either CD11b-CD18 or CD11c-CD18 but not with CD11a-CD18. The interaction was specifically inhibited by anti-CD11b or anti-CD11c, respectively, and by anti-CD23 MAbs. The functional significance of this ligand pairing was demonstrated by triggering CD11b and CD11c on monocytes with either recombinant CD23 or anti-CD11b and anti-CD11c MAbs to cause a marked increase in nitrite-oxidative products and pro-inflammatory cytokines (IL-1 beta, IL-6, and TNF alpha). These CD23-mediated activities were decreased by Fab fragments of MAbs to CD11b, CD11c, and CD23. These results demonstrate that CD11b and CD11c are receptors for CD23 and that this novel ligand pairing regulates important activities of monocytes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621072     DOI: 10.1016/1074-7613(95)90164-7

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  36 in total

1.  Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.

Authors:  S N Karagiannis; J K Warrack; K H Jennings; P R Murdock; G Christie; K Moulder; B J Sutton; H J Gould
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 2.  CD23/FcεRII: molecular multi-tasking.

Authors:  M Acharya; G Borland; A L Edkins; L M Maclellan; J Matheson; B W Ozanne; W Cushley
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

3.  Transfer of type II collagen-induced arthritis from DBA/1 to severe combined immunodeficiency mice can be prevented by blockade of Mac-1.

Authors:  P C Taylor; C Q Chu; C Plater-Zyberk; R N Maini
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

4.  Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells: stimulation by soluble CD23.

Authors:  V Roman; N Dugas; A Abadie; C Amirand; H Zhao; B Dugas; J P Kolb
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

5.  Differential regulation of monocyte cytokine release by αV and β(2) integrins that bind CD23.

Authors:  Adrienne L Edkins; Gillian Borland; Mridu Acharya; Richard J Cogdell; Bradford W Ozanne; William Cushley
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

6.  Increased CD14+ and decreased CD14- populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients.

Authors:  A Kyrgidis; M P Yavropoulou; R Lagoudaki; C Andreadis; K Antoniades; D Kouvelas
Journal:  Osteoporos Int       Date:  2016-11-17       Impact factor: 4.507

Review 7.  The emergence of ADAM10 as a regulator of lymphocyte development and autoimmunity.

Authors:  David R Gibb; Sheinei J Saleem; Natalia S Chaimowitz; Joel Mathews; Daniel H Conrad
Journal:  Mol Immunol       Date:  2011-01-13       Impact factor: 4.407

Review 8.  Soluble IgE receptors--elements of the IgE network.

Authors:  Barbara Platzer; Floortje Ruiter; John van der Mee; Edda Fiebiger
Journal:  Immunol Lett       Date:  2011-09-06       Impact factor: 3.685

9.  Aggregates of denatured proteins stimulate nitric oxide and superoxide production in macrophages.

Authors:  Szczepan Jozefowski; Janusz Marcinkiewicz
Journal:  Inflamm Res       Date:  2009-09-26       Impact factor: 4.575

10.  ADAM10 is essential for Notch2-dependent marginal zone B cell development and CD23 cleavage in vivo.

Authors:  David R Gibb; Mohey El Shikh; Dae-Joong Kang; Warren J Rowe; Rania El Sayed; Joanna Cichy; Hideo Yagita; John G Tew; Peter J Dempsey; Howard C Crawford; Daniel H Conrad
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.